Enovis (ENOV)
(Real Time Quote from BATS)
$55.13 USD
+0.03 (0.05%)
Updated Apr 26, 2024 09:44 AM ET
3-Hold of 5 3
B Value D Growth B Momentum C VGM
Income Statements
Fiscal Year end for Enovis Corporation falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 1,707 | 1,563 | 3,854 | 3,071 | 3,327 |
Cost Of Goods | 716 | 694 | 2,241 | 1,783 | 1,926 |
Gross Profit | 991 | 869 | 1,614 | 1,288 | 1,401 |
Selling & Adminstrative & Depr. & Amort Expenses | 1,056 | 941 | 1,357 | 1,126 | 1,197 |
Income After Depreciation & Amortization | -66 | -71 | 257 | 162 | 204 |
Non-Operating Income | 18 | 93 | -19 | 0 | -34 |
Interest Expense | 20 | 24 | 73 | 104 | 120 |
Pretax Income | -67 | -2 | 165 | 58 | 50 |
Income Taxes | -13 | 36 | 67 | -6 | 32 |
Minority Interest | 1 | 2 | 5 | 3 | 11 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -54 | -38 | 99 | 64 | 19 |
Extras & Discontinued Operations | 21 | 26 | -22 | -18 | -536 |
Net Income (GAAP) | -33 | -13 | 72 | 43 | -528 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 151 | 149 | 520 | 409 | 440 |
Depreciation & Amortization (Cash Flow) | 217 | 220 | 263 | 246 | 236 |
Income After Depreciation & Amortization | -66 | -71 | 257 | 162 | 204 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 54.53 | 53.17 | 51.83 | 46.30 | 45.21 |
Diluted EPS Before Non-Recurring Items | 2.40 | 2.27 | 6.42 | 4.20 | 6.99 |
Diluted Net EPS (GAAP) | -0.61 | -0.25 | 1.38 | 0.93 | -11.67 |
Fiscal Year end for Enovis Corporation falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | 455.02 | 417.52 | 428.50 | 406.15 |
Cost Of Goods | NA | 190.63 | 174.56 | 180.14 | 171.09 |
Gross Profit | NA | 264.39 | 242.97 | 248.36 | 235.07 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 270.14 | 263.46 | 262.86 | 260.03 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | -5.75 | -20.49 | -14.50 | -24.96 |
Non-Operating Income | NA | 17.67 | 0.76 | -0.75 | 0.66 |
Interest Expense | NA | 4.25 | 5.77 | 4.08 | 5.65 |
Pretax Income | NA | 7.66 | -25.50 | -19.32 | -29.96 |
Income Taxes | NA | 4.59 | -6.05 | -4.71 | -7.11 |
Minority Interest | NA | 0.12 | 0.04 | 0.18 | 0.19 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | 3.07 | -19.45 | -14.61 | -22.85 |
Extras & Discontinued Operations | NA | 0.01 | 16.61 | 4.80 | -0.31 |
Net Income (GAAP) | NA | 2.96 | -2.88 | -10.00 | -23.35 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | 59.28 | 55.07 | 55.53 | 54.84 |
Diluted EPS Before Non-Recurring Items | NA | 0.79 | 0.56 | 0.61 | 0.44 |
Diluted Net EPS (GAAP) | NA | 0.05 | -0.05 | -0.18 | -0.43 |